vs
M-tron Industries, Inc.（MPTI）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
M-tron Industries, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.6倍（$14.2M vs $9.1M），M-tron Industries, Inc.净利率更高（24.1% vs -60.3%，领先84.4%），M-tron Industries, Inc.同比增速更快（11.2% vs -49.9%），M-tron Industries, Inc.自由现金流更多（$2.3M vs $1.6M），过去两年M-tron Industries, Inc.的营收复合增速更高（12.8% vs -6.7%）
M-tron Industries, Inc.是一家研发生产高性能频率控制与计时解决方案的企业，产品涵盖晶体振荡器、滤波器、集成计时组件等，主要服务航空航天、国防、电信、工业自动化、医疗设备领域，客户覆盖北美、欧洲及亚洲的商业和政府机构。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
MPTI vs PLX — 直观对比
营收规模更大
MPTI
是对方的1.6倍
$9.1M
营收增速更快
MPTI
高出61.1%
-49.9%
净利率更高
MPTI
高出84.4%
-60.3%
自由现金流更多
MPTI
多$707.0K
$1.6M
两年增速更快
MPTI
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.2M | $9.1M |
| 净利润 | $3.4M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 27.3% | -51.1% |
| 净利率 | 24.1% | -60.3% |
| 营收同比 | 11.2% | -49.9% |
| 净利润同比 | 60.1% | -184.8% |
| 每股收益（稀释后） | $0.90 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPTIPLX
| Q4 25 | $14.2M | $9.1M | ||
| Q3 25 | $14.2M | $17.9M | ||
| Q2 25 | $13.3M | $15.7M | ||
| Q1 25 | $12.7M | $10.1M | ||
| Q4 24 | $12.8M | $18.2M | ||
| Q3 24 | $13.2M | $18.0M | ||
| Q2 24 | $11.8M | $13.5M | ||
| Q1 24 | $11.2M | — |
净利润MPTIPLX
| Q4 25 | $3.4M | $-5.5M | ||
| Q3 25 | $1.8M | $2.4M | ||
| Q2 25 | $1.6M | $164.0K | ||
| Q1 25 | $1.6M | $-3.6M | ||
| Q4 24 | $2.1M | $6.5M | ||
| Q3 24 | $2.3M | $3.2M | ||
| Q2 24 | $1.7M | $-2.2M | ||
| Q1 24 | $1.5M | — |
毛利率MPTIPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率MPTIPLX
| Q4 25 | 27.3% | -51.1% | ||
| Q3 25 | 18.0% | 11.9% | ||
| Q2 25 | 13.9% | 7.5% | ||
| Q1 25 | 15.8% | -41.0% | ||
| Q4 24 | 20.1% | 39.6% | ||
| Q3 24 | 22.1% | 22.2% | ||
| Q2 24 | 17.8% | -18.0% | ||
| Q1 24 | 16.0% | — |
净利率MPTIPLX
| Q4 25 | 24.1% | -60.3% | ||
| Q3 25 | 12.9% | 13.2% | ||
| Q2 25 | 11.7% | 1.0% | ||
| Q1 25 | 12.8% | -35.8% | ||
| Q4 24 | 16.7% | 35.6% | ||
| Q3 24 | 17.2% | 18.0% | ||
| Q2 24 | 14.8% | -16.4% | ||
| Q1 24 | 13.3% | — |
每股收益（稀释后）MPTIPLX
| Q4 25 | $0.90 | $-0.06 | ||
| Q3 25 | $0.63 | $0.03 | ||
| Q2 25 | $0.53 | $0.00 | ||
| Q1 25 | $0.56 | $-0.05 | ||
| Q4 24 | $0.68 | $0.10 | ||
| Q3 24 | $0.81 | $0.03 | ||
| Q2 24 | $0.63 | $-0.03 | ||
| Q1 24 | $0.53 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.9M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $63.2M | $48.2M |
| 总资产 | $68.4M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MPTIPLX
| Q4 25 | $20.9M | $14.7M | ||
| Q3 25 | $18.3M | $13.6M | ||
| Q2 25 | $15.5M | $17.9M | ||
| Q1 25 | $13.7M | $19.5M | ||
| Q4 24 | $12.6M | $19.8M | ||
| Q3 24 | $8.5M | $27.4M | ||
| Q2 24 | $6.5M | $23.4M | ||
| Q1 24 | $5.4M | — |
股东权益MPTIPLX
| Q4 25 | $63.2M | $48.2M | ||
| Q3 25 | $37.0M | $52.9M | ||
| Q2 25 | $34.8M | $49.9M | ||
| Q1 25 | $33.2M | $45.2M | ||
| Q4 24 | $31.3M | $43.2M | ||
| Q3 24 | $26.2M | $32.4M | ||
| Q2 24 | $23.7M | $28.6M | ||
| Q1 24 | $21.7M | — |
总资产MPTIPLX
| Q4 25 | $68.4M | $82.3M | ||
| Q3 25 | $42.2M | $82.3M | ||
| Q2 25 | $39.7M | $78.5M | ||
| Q1 25 | $37.8M | $73.9M | ||
| Q4 24 | $36.6M | $73.4M | ||
| Q3 24 | $31.5M | $61.6M | ||
| Q2 24 | $28.4M | $91.5M | ||
| Q1 24 | $26.8M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $1.6M |
| 自由现金流率自由现金流/营收 | 16.4% | 17.8% |
| 资本支出强度资本支出/营收 | 2.4% | 4.4% |
| 现金转化率经营现金流/净利润 | 0.78× | — |
| 过去12个月自由现金流最近4个季度 | $8.1M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流MPTIPLX
| Q4 25 | $2.7M | $2.0M | ||
| Q3 25 | $3.5M | $-3.7M | ||
| Q2 25 | $2.9M | $-5.2M | ||
| Q1 25 | $1.6M | $-5.1M | ||
| Q4 24 | $1.8M | $4.0M | ||
| Q3 24 | $2.3M | $4.1M | ||
| Q2 24 | $2.0M | $-3.6M | ||
| Q1 24 | $1.5M | — |
自由现金流MPTIPLX
| Q4 25 | $2.3M | $1.6M | ||
| Q3 25 | $2.7M | $-4.2M | ||
| Q2 25 | $2.0M | $-5.7M | ||
| Q1 25 | $1.0M | $-5.4M | ||
| Q4 24 | $1.4M | $3.6M | ||
| Q3 24 | $1.8M | $4.0M | ||
| Q2 24 | $1.1M | $-3.8M | ||
| Q1 24 | $1.4M | — |
自由现金流率MPTIPLX
| Q4 25 | 16.4% | 17.8% | ||
| Q3 25 | 19.1% | -23.7% | ||
| Q2 25 | 15.4% | -36.2% | ||
| Q1 25 | 8.0% | -53.0% | ||
| Q4 24 | 10.8% | 19.6% | ||
| Q3 24 | 13.4% | 22.4% | ||
| Q2 24 | 9.2% | -28.1% | ||
| Q1 24 | 12.3% | — |
资本支出强度MPTIPLX
| Q4 25 | 2.4% | 4.4% | ||
| Q3 25 | 5.7% | 2.8% | ||
| Q2 25 | 6.1% | 2.8% | ||
| Q1 25 | 4.6% | 3.0% | ||
| Q4 24 | 3.3% | 2.3% | ||
| Q3 24 | 3.6% | 0.5% | ||
| Q2 24 | 7.4% | 1.3% | ||
| Q1 24 | 1.1% | — |
现金转化率MPTIPLX
| Q4 25 | 0.78× | — | ||
| Q3 25 | 1.92× | -1.58× | ||
| Q2 25 | 1.83× | -31.91× | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.85× | 0.61× | ||
| Q3 24 | 0.99× | 1.27× | ||
| Q2 24 | 1.12× | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MPTI
| US | $11.3M | 79% |
| Non Us | $2.9M | 21% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
